Enliven Therapeutics (ELVN) Non-Current Assets (2019 - 2026)
Enliven Therapeutics (ELVN) reported Non-Current Assets of $2.88 million for Q2 2026, down 65.1% from $8.27 million a year earlier but up 68.2% from the prior quarter.
Enliven Therapeutics (ELVN) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics posted Non-Current Assets of $1.29 million, down 83.1% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 24.2% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $7.63 million in FY2024 (+33.5%), $5.72 million in FY2023 (+3.1%), $5.55 million in FY2022 (+483.7%) and $950,000 in FY2021 (+117.4%).
- Five-year quarterly Non-Current Assets spans a low of $410,000 in Q2 2022 and a high of $8.92 million in Q2 2024.
- Year over year, Non-Current Assets has now declined in each of the last five quarters, with an average decline of 12.6% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q4 2022 (growth of 483.7%); the low point was Q4 2025 (a decline of 83.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.72 million (Q1 2026), $1.29 million (Q4 2025) and $8.19 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Enliven Therapeutics | 2.77 Bn | 482.20 Mn | - | 2.88 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 8.19 Mn |
| Jun 30, 2025 | 8.27 Mn |
| Mar 31, 2025 | 8.25 Mn |
| Dec 31, 2024 | 7.63 Mn |
| Sep 30, 2024 | 8.43 Mn |
| Jun 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | 5.58 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Sep 30, 2023 | 5.44 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 4.86 Mn |
| Dec 31, 2022 | 5.55 Mn |
| Jun 30, 2022 | 410,000.00 |
| Mar 31, 2022 | 3.07 Mn |
| Dec 31, 2021 | 950,000.00 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.11 Mn |
Enliven Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ELVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();